Drug intelligence / Profile preview

Placental-derived mesenchymal stem cells (Kasr El Aini Hospital)

Development stage: Unknown
Lead developer: Kasr Al Ainy Hospital
Modality: Stem Cell Therapies → Cell Therapies
Administration: Intrauterine

Overview

Placental-derived mesenchymal stem cells (PMSCs) are an investigational cell therapy developed by Kasr El Aini Hospital for the treatment of infertility and recurrent implantation failure. These multipotent stem cells are isolated from placental tissue and can be administered to the uterine cavity in either an undifferentiated state or after differentiation into endometrium-like cells. The therapy aims to improve endometrial receptivity and thickness by promoting tissue regeneration and increasing vascularity, thereby enhancing the success rates of embryo implantation during assisted reproductive technology (ART) procedures such as ICSI.

Other names: placental-derived MSCPMSCsplacental-derived mesenchymal stem cells

Beyond the preview

Go deeper on Placental-derived mesenchymal stem cells (Kasr El Aini Hospital).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Placental-derived mesenchymal stem cells (Kasr El Aini Hospital).

Explore the full profile